gadodiamide

Name: Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]- (Related Reference) Molecular Formula: C16H26GdN5O8 CAS Registry Number: 131410-48-5 Synonyms: DV 7572; Gadolinium-DTPA-BMA; Gd DTPA-BMA; S 041; InChI: InChI=1/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3 Molecular Structure: Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]- C16H26GdN5O8 (cas 131410-48-5) Molecular Structure
Used as pharmaceuticals and biochemicals

CAS NO:131410-48-5

EC NO:

Molecular Formula:C₁₆H₂₆GdN₅O₈

Molecular Weight:573.6563

Synonyms:gadolinium 2-[bis[2-(carboxylatomethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetate;GADODIAMIDE (500 MG);Omniscan;[5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraaza-tridecan-13-oato(3-)]gadolinium;Gd-DTPA-BMA;S-041;gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oate (non-preferred name);

Molecular Structure: